still, for most people semaglutide should be good enough 1 Like Neo September 8, 2024, 8:26pm #5 RapAdmin: tested in the ITP program They should something in this broader family, but issues in the past has been needs to be pill/food based and not subcutaneous injections 1 Like Neo September 8, 2024, 8:27pm #6 AlexKChen: widely available on various peptide sites now Any sense of this increased baseline insulin levels, thats my worry with GLP-1 as CR mimetic that key longevity pathway (and IGF, etc) might actually go in the wrong direction with these HealthspanMaximalist September 10, 2024, 2:07am #7 2.2% is quite a large A1C reduction (although the sample size was not that big)
Adjusting protocols based on progress requires thoughtful interpretation of available data
That, he suggested, could create opportunities for employers to structure GLP-1 coverage similarly to retirement benefits, with eligibility tied to tenure and coverage "vesting" after a defined period of employment
The potential benefits highlighted in this video apply to the specific ingredients, and may not necessarily apply to a combination of those ingredients
They measure acetoacetate excretion, which decreases as the body becomes more efficient at using ketones
"I was on Wegovy and recently switched to Ozempic, for a total of about six months between the two
